DOI QR코드

DOI QR Code

The Retrospective Analysis of Effects of H Gambitang (GB-001) on Weight Loss in Pre- and Post-Menopausal Obese Woman

H 감비탕(GB-001)이 폐경 전·후 비만 여성의 체중감량에 미치는 영향에 대한 후향적 연구

  • Cho, Hong Seok (Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Seo, Yeonho (Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Koh-Woon (Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Cho, Jae-Heung (Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Song, Mi-Yeon (Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University)
  • 조홍석 (경희대학교 한의과대학 한방재활의학과교실) ;
  • 서연호 (경희대학교 한의과대학 한방재활의학과교실) ;
  • 김고운 (경희대학교 한의과대학 한방재활의학과교실) ;
  • 조재흥 (경희대학교 한의과대학 한방재활의학과교실) ;
  • 송미연 (경희대학교 한의과대학 한방재활의학과교실)
  • Received : 2020.04.16
  • Accepted : 2020.06.09
  • Published : 2020.06.30

Abstract

Objectives: The purpose of this study is to verify the effects of H Gambitang (GB-001) on body composition and basal metabolic rate in pre- and post-menopausal obese woman retrospectively. Methods: The study was conducted on 57 middle-aged obese women. They were divided into two groups; pre-menopausal obesity group (Pr-MOG; n=34) and post-menopausal obesity group (Po-MOG; amenorrhea was continued to 14~48 month, n=23) with no significant difference of age, height, body weight and body mass index. All subjects took herbal medicine 3 times a day, for 6 weeks during treatment period. The weight, height, body fat mass, skeletal muscle mass, and basal metabolic rate of all subjects were measured on first visit. The following measurements were repeated after 2 weeks (2nd), 4 weeks (3rd) and 6 weeks (4th) with Inbody 370 (Biospace) equipment to identify changes of body fat mass, skeletal muscle mass, and basal metabolic rate. Results are represented as mean and standard deviation. Results: Po-MOG showed significantly lower decrease rate in weight reduction on 2~6 weeks while significantly higher decrease rate in skeletal muscle reduction on 4~6 weeks. There were no significant differences between two groups in body fat reduction rate and basal metabolic increasing rate. Conclusions: H Gambitang (GB-001) can be used not only in Pr-MOG but in Po-MOG in weight loss although the effect can be lower in Po-MOG. To prevent skeletal muscle mass loss in Po-MOG, following study on adjusting dose and components of H Gambitang (GB-001) thought to be necessary.

Keywords

References

  1. Park YJ, Sim MJ, Kim HJ, Jeon NM, Kim HY, Lee ES, et al. Maternity & women's health nursing. 4th ed. Seoul : Hyunmoonsa. 2017 : 241-4.
  2. Huh JY, An HJ. The effects of yoga performance on mental health in menopause women. The Korea Journal of Sports Science. 2007 ; 16(2) : 361-71.
  3. The Compilation Committee of Korea Society of Menopause. Menopause Health. Paju : Koonja Publishing. 2012.
  4. Nelson HD. Menopause. Lancet. 2008 ; 371(9614) : 760-70. https://doi.org/10.1016/S0140-6736(08)60346-3
  5. Gong KM, Kim KJ. Comparison of association of exercise participation with abdominal fat area, insulin resistance, and blood lipid profiles between pre-menopausal and post-menopausal women. The Korean Journal of Growth and Development. 2007 ; 15(1) : 9-17.
  6. Hagey AR, Warren MP. Role of exercise and nutrition in menopause. Clinical Obstetrics and Gynecology. 2008 ; 51(3) : 627-41. https://doi.org/10.1097/GRF.0b013e318180ba84
  7. Park YJ, Koo BS, Kang HC, Chun SH, Yoon JW. The menopausal age and climacteric symptoms, and the related factors of Korean women. Korean J Women Health Nurs. 2001 ; 7(4) : 473-85. https://doi.org/10.4069/kjwhn.2001.7.4.473
  8. American College of Sports Medicine. Guidelines for exercise testing and prescription. 7th ed. Philadelphia : Lippincott Williams & Wilkins. 2005.
  9. Monzillo L, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutrition Reviews. 2003 ; 61 : 397-412. https://doi.org/10.1301/nr.2003.dec.397-412
  10. Choi SH. Acupuncture for obesity: a systematic review and meta-analysis. International Journal of Obesity. 2009 ; 33 : 183-96. https://doi.org/10.1038/ijo.2008.269
  11. Jung SK. Effect of Taeyeumjoweetang and electroacupuncture combined therapy on obesuty. J Korea Orein Assoc Stud Obes. 2003 ; 3(1) : 61-7.
  12. Hwang DS. The efficacy of low frequency electroacupuncture therapy for weight loss in obese Korean women. The Journal of Oriental Obstetrics & Gynecology. 2009 ; 22(2) : 140-50.
  13. Hyeon C, Seo GS, Shin WY. The retrospective analysis of obesity and overweight female patients with clinical treatment including herbal medicine. The Journal of Society of Korea Medicine Obstetrics and Gynecology. 2016 ; 29(3) : 35-46.
  14. Jang IS, Yang CS, Hwang EH. The need for clinical practice guidelines in usage of Mahuang in weight loss. Journal of Society of Korean Medicine for Obesity Research. 2007 ; 7(1) : 23-9.
  15. Song YK, Lim HH. Clinical application of Ma Huang in the obesity treatment. Journal of Society of Korean Medicine for Obesity Research. 2007 ; 7(1) : 1-7.
  16. Song MY, Kim HJ, Lee MJ. The safety guidelines for use of Ma-huang in obesity treatment. Journal of Society of Korean Medicine for Obesity Research. 2006 ; 6(2) : 17-27.
  17. Kim HJ, Han CH, Lee EJ, Song YK, Shin BC, Kim YK. A clinical practice guideline for Ma-huang, ephedra sinica prescription in obesity. Journal of Society of Korean Medicine for Obesity Research. 2007 ; 7(2) : 27-37.
  18. Greenway FL, DE Jonge L, Blanchard D, Frisard M, Smith SR. Effect of dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obese Res. 2004 ; 12(7) : 1152-7. https://doi.org/10.1038/oby.2004.144
  19. Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000 - mainly about ephedra herba. Journal of Society of Korean Medicine for Obesity Research. 2007 ; 7(1) : 39-54.
  20. Shekelle P, Hardy ML, Morton SC, Maglione M, Suttorp M, Roth E, et al. Ephedra and ephedrine for weight loss and athletic performance enhancement: Clinical efficacy and side effects. Evid Rep Technol Assess. 2003 ; 76 : 1-4.
  21. Gruenwald J, Brender T, Jaenicke C. PDR for herbal medicines. 3rd ed. Whippany : Physicians Desk Reference. 2004 : 531-9.
  22. Mills S, Bone K. The essential guide t o herbal safety. London : Churchill Livingstone. 2005 : 380-3.
  23. Yeo JJ, Hyung LC, Yang CS, Jeong SI, Seo ES, Jang JS. Effects of Mahuang for weight loss in healthy adults: a double-blind, controlled, randomized, clinical trial. The Society of Korea Medicine. 2007 ; 28(1) : 63-71.
  24. Kang MH. Effect of ephedra on the anxiety according to Sasang constitution classification. Doctoral Thesis. Wanju : Woosuk University. 2009.
  25. Jang IS, Yang CS, Lee SD, Han CH. A review of herbal medicinal products associated with toxic events in Korea. Journal of Korean Medicine. 2007 ; 28(1) : 1-10.
  26. Jo SH. The effects of Gamchomahwang-tang extract according to the ratio of 2 compounds on the ovalbumin- induced allergic asthma in mice. Master's Thesis. Iksan : Wonkwang University. 2013.
  27. Song MK. The effects of Ephedrae Herba on obese type 2 diabetes mouse model induced by high fat, high carbonate diet. Master's Thesis. Seoul : Kyung Hee University. 2009.
  28. Lee TH. Adverse effects of Mahuang according to Sasang constitution classification in healthy adults: a double-blind randomized controlled trial. Doctoral Thesis. Wanju : Woosuk University. 2006.
  29. Li CH. Short-term effects of Mahuang on state-trait anxiety according to Sasang constitution classification: a double-blind randomized controlled trial. Master's Thesis. Wanju : Woosuk University. 2007.
  30. Ryu SM, Jeong SH, Lee JS, Kim SS, Shin HD. The effect of very low calorie diet and Chegamuiyiin-tang on bone mineral density. J Korean Med Obes Res. 2005 ; 5 : 87-95.
  31. Kim SJ, Kim HJ, Ko BP, Kim HD, Kim JA, Park JM, et al. Effect of Ephedra Sinica and Evodia Rutaecarpa on resting metabolic rate in obese Prem enopausal women during low-calorie diet : a randomized controlled clinical trial. J Korean Med Obes Res. 2004 ; 4 : 45-54.
  32. Nam EY. The systematic review on clinical studies of traditional Korean medicine treatment for obesity in menopausal women. J Korean Med Obes Res. 2019 ; 19(1) : 56-67. https://doi.org/10.15429/jkomor.2019.19.1.56
  33. Park HR. The research regarding the awareness and practice of weight and skin care of middle-aged women. Master's Thesis. Seoul : Kookmin University. 2003.
  34. North America Menopause Society. Treatment of menopause-associated vasomotor symptoms; position statement of The North America Menopause Society. Menopause. 2004 ; 11(1) : 11-33. https://doi.org/10.1097/01.GME.0000108177.85442.71
  35. Choi JH, Yang JH. Effects of Antioxidant supplementation and exercise frequency to body composition, peroxide value and total antioxidant status in obese women. Journal of Sport and Leisure Studies. 2009 ; 36(2) : 635-42. https://doi.org/10.51979/KSSLS.2009.05.36.635
  36. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med. 1995 ; 123(9) : 673-5. https://doi.org/10.7326/0003-4819-123-9-199511010-00005
  37. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med. 1991 ; 151 : 97-102. https://doi.org/10.1001/archinte.1991.00400010111016
  38. Kim YS. Management of obesity in postmenopausal women. The Journal of the Korean Medical Association. 2005 ; 48(4) : 349-53. https://doi.org/10.5124/jkma.2005.48.4.349
  39. Lovejoy JC. The menopause and obesity. Prim Care. 2003 ; 30(2) : 317-25. https://doi.org/10.1016/S0095-4543(03)00012-5